Source: Annual Congress 2003 - Non-steroidal drugs in the treatment of respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. A. Biernacki, H. M. Biernacka, S. A. Kharitonov, P. J. Barnes (London, United Kingdom). Cysteinyl leukotrienes and leukotriene B₄ in expired breath condensate in patients with chronic asthma treated with montelukast. Eur Respir J 2003; 22: Suppl. 45, 710

Member's Comments

No comment yet.

Related content which might interest you: Increased exhaled cysteinyl-leukotrienes, leukotriene B4 and 8-isoprostane in exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Leukotriene B4 in breath condensate in patients with exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001 Cysteinyl leukotrienes in urine and exhaled breath condensate in asthmatics and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 The effect of smoking on the levels of cysteinyl leukotriene in exhaled breath condensate in asthmatics Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Cysteinyl leukotrienes in exhaled breath condensate are reduced after mite avoidance in allergic asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 412s Year: 2002 Corticosteroid reversibility testing and exhaled leukotriene B4 in patients with stable, severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002 Increased exhaled breath condensate cysteinyl leukotriene concentration in exercise-induced bronchoconstriction Source: Annual Congress 2011 - Clinical application of exhaled biomarkers Year: 2011 Leukotriene B4 in exhaled breath condensate of patients after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001 Saliva is one likely source of leukotriene B4 in exhaled breath condensate Source: Eur Respir J 2006; 28: 1229-1235 Year: 2006 Leukotrienes and 8-isoprostane in exhaled breath condensate of children with asymptomatic steroid-naive asthma Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Thromboxane B2 and prostaglandin E2 concentrations in exhaled breath condensate in healthy volunteers and patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002 Therapeutical impact of montelukast on exhaled leukotrienes in asthmatic children Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006 Prostaglandin E2 in the expired breath condensate of patients with asthma Source: Eur Respir J 2003; 22: 743-747 Year: 2003 8-isoprostane and cys-leukotrienes in exhaled breath condensate (EBC) of children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Leukotriene metabolites in breath condensate of patients with atopic asthma and cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 232s Year: 2003 Leukotrienes in exhaled breath condensate of children with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 39s Year: 2001 Cysteinyl leukotrienes in exhaled breath condensate in children: noninvasive marker of remodeling? Source: Eur Respir J 2003; 22: Suppl. 45, 397s Year: 2003 Leukotriene B4 levels in sputum from asthma patients Source: ERJ Open Res, 2 (4) 00088-2015; 10.1183/23120541.00088-2015 Year: 2016 Changes in sputum concentrations of leukotrienes and thromboxane after dry air hyperventilation in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 412s Year: 2003 Measurements of prostaglandins E2 and D2 and their metabolites in exhaled breath condensate following bronchial provocation with aspirin in asthmatics Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013